FDA clarifies EUAs for COVID multi-analyte respiratory panels
The Agency added a new item to its questions and answers (Q&As) for laboratories and manufacturers of tests for SARS-CoV-2, the virus that causes COVID-19. The new Q&A cites “the overlap in signs and symptoms between SARS-CoV-2 and other respiratory viral infections, including influenza.” Multi-analyte panels for respiratory infections, noted the Agency, “are useful when … Read more